Statins: to switch or not to switch?
Authors
Abstract
Two doctors argue for and against the policy of switching patients from expensive branded statins to lower‐cost generic formulations in order to reduce NHS prescribing costs. Copyright © 2008 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.221 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
